Norman Ng: Highlighting the need for lung cancer screening in Asia
Norman Ng, Director of Patient Advocacy and Public Affairs at Healthcare Thinkers, shared a post on LinkedIn:
“Dr. Molly Li, Assistant Professor at the Department of Clinical Oncology, The Chinese University of Hong Kong, stated:
‘Although significant breakthroughs have been made in recent years in the treatment of late-stage lung cancer, as doctors, we always advocate for early diagnosis and treatment, as this remains the most effective approach.’
The Importance and Current Situation of Lung Cancer Screening
According to Dr. Li’s clinical experience, early symptoms of lung cancer are often difficult to detect, and many patients who seek medical attention are already in the middle or late stages of the disease. In response to this, various regions have actively implemented low-dose CT screening programs to detect abnormalities early and initiate treatment.
Notably, the Taiwanese government now recommends that high-risk individuals undergo low-dose CT lung cancer screening every two years. Meanwhile, similar screening programs in Hong Kong are still in their early stages.
Prof. Tony Mok, the Chairman and Li Shu Fan Professor of the Department of Clinical Oncology at The Chinese University of Hong Kong, has emphasized the importance of lung cancer screening.
He mentioned in a program that even non-smokers with a family history of lung cancer have a significantly higher risk of developing the disease.
According to 2023 research data from Taiwan, the early-stage lung cancer detection rate among this group is 2.6%.
Proceed to the video attached to the post.
More posts featuring Norman Ng.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023